|
|
Pharmaceutical and Biomedical Research، جلد ۱، شماره ۱، صفحات ۳۲-۳۶
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Demographic and clinical characteristics of gastric cancer patients in north of Iran, Mazandaran province, 2008-2014 |
|
| چکیده انگلیسی مقاله |
Gastric cancer has been known as a poor prognosis disease with a high degree of mortality. In Iran, it has been increased during the previous two decades, especially in northern part of the country. The aim of this study was to determine the demographic and clinical characteristics of gastric cancer in Mazandaran province. All patients with gastric cancer diagnosis treated in the Imam Khomeini educational hospital or Touba Polyclinic, a university affiliated center, from March 2008 to March 2014 were included. Demographic data, the symptoms at the time of presentation, tumor size, type of tumor, lymph node involvement, status in terms of metastatic disease, therapeutic plan and type of chemotherapy regimens were gathered from patients’ medical records. Statistical analysis was performed using SPSS, version 16. Totally, 643 patients were investigated. The mean age of patients were 64.34 years and men were more affected than women. “Time to relapse” and “time to progression” were 13 and 6.5 months, respectively. The most common initial symptoms at diagnosis were nausea, vomiting and epigastric pain (47.4%). Only in 6.3%, the disease was diagnosed at the initial stages. The most common site of involvement was cardia (almost 40%) and antrum (32%). More than 91% of tumors were adenocarcinoma. DCF (Docetaxel, Cisplatin, 5FU) (43.3%), Xeloda (15.2%), DOX (Docetaxel.Oxaliplatin) (13.8%) and ECF (Epirubicin.Cisplatin.5FU) (9.2%) were the most common used regimens. There was a trend for improved survival with DCF regimen (P=0.08). Most gastric cancer patients were referred in the advanced stage or metastatic disease. The demographic characteristics are consistent with other previous reports. DCF regimen may have some advantages over the other chemotherapy regimens. |
|
| کلیدواژه‌های انگلیسی مقاله |
Gastric Cancer, Demographic, Chemotherapy, DCF, Mazandaran |
|
| نویسندگان مقاله |
سیدخلیل موسوی | seyed khalil mousavi
students research committee, faculty of pharmacy, mazandaran university of medical sciences, mazandaran, sari. iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
قاسم جان بابایی | ghasem janbabai
department of hematology and oncology, cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
بیژن کوچکی | bizhan kouchaki
students research committee, faculty of pharmacy, mazandaran university of medical sciences, mazandaran, sari. iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
هانیه برهانی | hanieh borhani
cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
معصومه رشیدی | masoumeh rashidi
cancer research center, imam khomeini hospital, mazandaran university of medical sciences, sari, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
ابراهیم صالحی فر | ebrahim salehifar
department of clinical pharmacy, pharmaceutical research center, mazandaran university of medical sciences, sari, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی مازندران (Mazandaran university of medical sciences)
|
|
| نشانی اینترنتی |
http://pbr.mazums.ac.ir/browse.php?a_code=A-10-26-4&slc_lang=en&sid=en |
| فایل مقاله |
اشکال در دسترسی به فایل - ./files/site1/rds_journals/1789/article-1789-282469.pdf |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
داروسازی بالینی |
| نوع مقاله منتشر شده |
پژوهشی |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|